§ Federal grant opportunity · F26AS00084
F26AS00084 Aquatic Invasive Species Grants to Great Lakes Tribes - Fiscal Year 2026 Great Lakes Restoration Initiative
Fish and Wildlife Service is accepting applications for F26AS00084 Aquatic Invasive Species Grants to Great Lakes Tribes - Fiscal Year 2026 Great Lakes Restoration Initiative. The deadline is December 31, 2026 and the published award range is $20K – $100K.
Key facts
- Funder
- Fish and Wildlife Service
- Application deadline
- December 31, 2026
- Award range
- $20K – $100K
- Eligibility
- We are seeking applications from tribal natural resource agencies/organizations in the Great Lakes Basin. However, a tribal agency may designate an entity (of any type) to apply for the award on their behalf.
- Geography
- United States
- Focus areas
- Environment
- Opportunity number
- F26AS00084
Program overview
Using appropriations to the Great Lakes Restoration Initiative (GLRI), the U.S. Fish and Wildlife Service (FWS) anticipates providing grants to support development and/or implementation of Great Lakes Tribal Aquatic Invasive Species Management Plans (Tribal AIS Plans). Therefore, a Tribal AIS Plan must be in place that supports the proposed work, or development of such a plan must be a part of the proposed work. All tribal grants will be awarded based on a competitive process for which only Great Lakes tribes or their designee are eligible.
How to apply
- Confirm your organization meets the eligibility criteria above.
- Read the full funding opportunity announcement from Fish and Wildlife Service.
- Draft your narrative against the funder's stated priorities and review criteria.
- Submit before December 31, 2026, allowing time for registration and validation.
Related grant opportunities
- ROSES 2025: A.4 Rapid Response and Novel Research in Earth Science
- ERDC Broad Agency Announcement
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
Find every grant your organization qualifies for
Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.